COMPARISON OF THE BURDEN AND COST DRIVERS OF COPD HOSPITALIZATION BETWEEN HISPANIC AND WHITE POPULATION IN THE UNITED STATES

Author(s)

Borrego M1, Roberts M2, Petersen H3, Kharat AA1, Blanchette C41University of New Mexico, Albuquerque, NM, USA, 2University of New Mexico College of Pharmacy, Albuquerque, NM, USA, 3Center for Pharmacoeconomic and Outcomes Research, Albuquerque, NM, USA, 4

OBJECTIVES: The purpose of the study is to compare the costs, cost drivers and prevalence of COPD-related hospitalizations for Hispanic and White patients in US hospitals. METHODS: A retrospective cohort of COPD related hospitalized patient discharges in 2007 were identified from a nationally representative database of over 500 hospitals. Subjects were included if they had primary diagnosis code for COPD (ICD9-CM 491, 492 or 496), Hispanic or White race and of age >18. COPD related discharge rates for US population were calculated using hospital discharge data and projection weight methodology and were further stratified by race.  Hispanic discharges were matched (1:3) to comparison group of White discharges by sex, severity score, and 5-year age ranges for an analysis of mortality and mean costs. Unadjusted mortality and mean costs were compared by race, and cost drivers were identified using a gamma generalized linear model incorporating generalized estimating equations to account for the non-independent matched discharges.  RESULTS: The calculated national estimates for COPD related discharges were: 490,636 total discharges including 71.4% White and 2.6% (n=12,661) Hispanic. The study population was comprised of a cohort of 1,644 Hispanic discharges meeting the inclusion criteria and a matched group of 4,932 White discharges. For matched discharges the mortality rate for Whites was significantly higher than Hispanics (1.4% White vs. 0.23% Hispanic, p=.006). Hispanics had significantly higher (P=.01) unadjusted mean total patient costs ($7,356) versus whites ($6,748), with no difference in length of stay.  Hispanic hospitalizations had significantly higher costs than White hospitalizations (P<.0001). Regression analysis identified the significant cost drivers:  severity score, Hispanic race, LOS, ICU days, urban hospital, and teaching hospital, (all with P<.025). CONCLUSIONS: As the Hispanic population and COPD prevalence continue to rise; differences in burden, cost, cost-drivers and treatment patterns in Hispanics warrant additional investigation in an attempt to target services and reduce the burden.

Conference/Value in Health Info

2011-05, ISPOR 2011, Baltimore, MD, USA

Value in Health, Vol. 14, No. 3 (May 2011)

Code

PRS9

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×